TNF and cardiovascular disorder: Furthermore, oral glucocorticoids or tumor necrosis factor-alpha (TNF-alpha) inhibitors also increase the risk of cardiovascular disease, and thus, patients with RA are more likely to be on these agents than the general population [4].